Date: December 9, 2021, Thursday
09:00 – 13:30 Singapore/China
10:00 – 14:30 Japan/Korea
12:00 – 16:30 Melbourne, Australia
14:00 – 18:30 Auckland, New Zealand
Venue: Virtual (Zoom Access)
Cancer immunotherapy achieves remarkable remissions in a subset of patients, but predictive markers are urgently needed to identify patients most likely to benefit. Multiplexed immunofluorescence (mIF) provides information not only about multiple markers on a cell, but spatial information about where different cells or cellular neighborhoods are located and how they interact to influence disease progression. Join us for this APAC user group meeting to learn how experts discover and establish the vital role of spatial biomarkers in setting the future directions in achieving precision Immuno-Oncology by using mIF technologies.